Intarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company committed to developing innovative therapies that merge medicine with technology, and have the potential to transform therapeutic categories.
We focus our efforts on serious diseases that are prevalent and poorly controlled. Our near-term goal is to deliver a game-changing new level of freedom for a vast number of patients with type 2 Diabetes. This is our future and our passion. Our major 2012 financing brings us a critical step closer to achieving this as we launch our global Phase 3 program for ITCA 650 entitled FREEDOM.
Our drug development expertise is a key competitive advantage, and is demonstrated by our ability to stabilize therapeutic proteins and peptides and to deliver them in a constant and consistent manner over an extended period of time via our unique and proprietary drug delivery platform. Our most advanced product is ITCA 650 in type 2 Diabetes (T2D). Currently in Phase 3 development, the investigational therapy holds significant promise as a 'game-changing' treatment in this increasingly common and important disease. Further information about ITCA 650 and the drug delivery platform is available in the Pipeline & Technology section of this website.
We have a very active and intense business development effort to seek partners to share the possibilities of our unique technology platform by bringing new and transformational products to other therapeutic areas. Our technology holds broad potential applications with pharmaceutical and biotechnology companies that have therapies in disease areas where poor patient tolerance to therapy and non-optimized treatment regimens represent significant obstacles to achieving treatment success.
At Intarcia, we foster an entrepreneurial environment for our carefully chosen talent, and work closely with key thought leaders and clinical investigators from academic centers of excellence. We are proud of our people and the culture of our company, and consistently strive to uphold our core values and our ethical integrity in everything we do.
Intarcia is privately held with its headquarters in Boston, MA, and manufacturing facilities in Hayward, CA.
Intarcia Therapeutics, Inc.
155 Seaport Boulevard
Boston, MA 02201
Phone: (617) 936-2500
Intarcia carefully maintains an environment based on our core values of innovation and integrity. We are comprised of talented and entrepreneurial people who enjoy collaborating and achieving excellent results. Our leaders are deeply experienced and extremely approachable executives who actively support our business plan and our team. Read more